Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Rui-Xiang Zeng et al., published in JACC Journals:
“Interesting to see cholesterol and inflammation portrayed as equal partners in atherosclerosis.
The problem is that the evidence is not remotely symmetrical.
For LDL-C lowering we have decades of randomized trials—4S, HPS, PROVE-IT, IMPROVE-IT, FOURIER, ODYSSEY, CLEAR Outcomes—consistently showing that lowering LDLc reduces cardiovascular events.
For anti-inflammatory therapy?
A small handful of trials, modest benefits, and sometimes meaningful safety concerns.
Inflammation matters.
No serious scientist denies that.
But putting cholesterol and inflammation on the same evidentiary level is a bit like calling a tie when one side is supported by a vast body of randomized trial evidence and the other by only limited clinical proof.
LDL isn’t just part of the story.
It’s the only target that has repeatedly proven in randomized trials that moving it changes outcomes.
Evidence first.
Symmetry later.”
Title: Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy
Authors: Rui-Xiang Zeng, Sha Li, Jian-Jun Li
Read the Full Article on JACC Journals
Other posts about Pablo Corral on Hemostasis Today.
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA
-
May 5, 2026, 15:28Soumen Bhattacharyya: Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
-
May 5, 2026, 15:06Wolfgang Miesbach: How Should We Approach GI Angiodysplasia in VWD?
-
May 5, 2026, 14:48What Constitutes High Risk for Venous Thromboembolism? – JTH
-
May 5, 2026, 14:41How Real-Time Data, Rehabilitation Registries, and Patient-Reported Outcomes Can Transform Practice – European Stroke Organisation
-
May 5, 2026, 14:41Driving National Change for Bleeding Disorders – WFH